HBT
GILD icon

Heartland Bank & Trust’s Gilead Sciences GILD Stock Holding History

Heartland Bank & Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$945K Buy
6,784
+206
+3% +$28.8K 0.21% 79
2025
Q4 		$807K Sell
6,578
-114
-2% -$13.9K 0.34% 62
2025
Q3 		$743K Buy
6,692
+3
+0% +$341 0.31% 72
2025
Q2 		$742K Sell
6,689
-185
-3% -$19.7K 0.35% 71
2025
Q1 		$770K Buy
+6,874
New +$709K 0.4% 65

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Heartland Bank & Trust's GILD Position: Q1 2026 in Review

Heartland Bank & Trust increased its Gilead Sciences (GILD) stake by 3.1% in Q1 2026, buying an estimated $28.8K and bringing the position to 6,784 shares worth $945K. The position accounts for 0.21% of the portfolio, ranked #79.

Heartland Bank & Trust first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. 2,312 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Heartland Bank & Trust held 6,784 shares of Gilead Sciences worth $945K as of Q1 2026.
  • Heartland Bank & Trust bought 206 Gilead Sciences shares in Q1 2026, an estimated $28.8K.
  • Gilead Sciences made up 0.21% of Heartland Bank & Trust's portfolio in Q1 2026, its #79 holding.
  • Heartland Bank & Trust first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • 2,312 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Heartland Bank & Trust's 13F filing for Q1 2026, filed 6 May 2026.